| Product Code: ETC10118109 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Industry Life Cycle |
3.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Porter's Five Forces |
3.5 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.8 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health disorders in Zambia |
4.2.2 Growing acceptance and adoption of alternative therapies for anxiety and insomnia |
4.2.3 Rising disposable income leading to higher spending on healthcare products |
4.3 Market Restraints |
4.3.1 Limited availability of gamma-aminobutyric acid (GABA) receptor agonists in Zambia |
4.3.2 Lack of healthcare infrastructure and facilities in remote areas |
4.3.3 Regulatory challenges and approval process for new drugs |
5 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends |
6 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Types |
6.1 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Insomnia, 2021- 2031F |
6.1.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.5 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Spasticity, 2021- 2031F |
6.1.6 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.1.7 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Zolpidem, 2021- 2031F |
6.2.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Topiramate, 2021- 2031F |
6.2.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.2.5 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Therapeutics |
6.3.1 Overview and Analysis |
6.3.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Bamaluzole, 2021- 2031F |
6.3.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Phenibut, 2021- 2031F |
6.3.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.3.5 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Gaboxadol, 2021- 2031F |
6.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Intrathecal, 2021- 2031F |
6.4.5 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Import-Export Trade Statistics |
7.1 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Export to Major Countries |
7.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Imports from Major Countries |
8 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare professionals prescribing GABA receptor agonists |
8.2 Patient satisfaction scores related to the efficacy of GABA receptor agonists |
8.3 Number of clinical trials conducted on new GABA receptor agonist formulations |
8.4 Adoption rate of GABA receptor agonists in different regions of Zambia |
8.5 Investment in research and development for improving GABA receptor agonist products |
9 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Opportunity Assessment |
9.1 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.4 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Competitive Landscape |
10.1 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Zambia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |